• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同型胱氨酸尿症杂合子:肺血栓栓塞可检测且可逆的危险因素。

Heterozygosity for homocysteinuria: a detectable and reversible risk factor for pulmonary thromboembolism.

作者信息

Confalonieri M, Parigi P, Scartabellati A, Aiolfi S, Patrini G, Ghio L, Mauri F, Gandola L

机构信息

Divisione di Pneumologia, Ospedale Maggiore di Crema, Italy.

出版信息

Monaldi Arch Chest Dis. 1995 Apr;50(2):114-5.

PMID:7613541
Abstract

Heterozygosity for homocysteinuria is a common, inherited autosomal condition that has recently been considered as an independent cardiovascular risk factor. In vitro and in vivo results suggest that this condition, like the homozygous form, is also a risk factor for deep-venous thrombosis and pulmonary thromboembolism. We report a case of recurrent pulmonary thromboembolism in a young woman with familial hyperhomocysteinaemia. The relative frequency of this condition, as well as its simple and harmless cure, make testing for heterozygosity for homocysteinuria useful and profitable in the prevention of pulmonary thromboembolism, above all in younger subjects with a significant case history.

摘要

同型胱氨酸尿症杂合子是一种常见的常染色体遗传性疾病,最近被认为是一种独立的心血管危险因素。体外和体内研究结果表明,这种情况与纯合子形式一样,也是深静脉血栓形成和肺血栓栓塞的危险因素。我们报告了一例年轻女性家族性高同型半胱氨酸血症反复发生肺血栓栓塞的病例。这种疾病的相对发病率及其简单无害的治疗方法,使得检测同型胱氨酸尿症杂合子在预防肺血栓栓塞方面有用且有益,尤其是在有重要病史的年轻患者中。

相似文献

1
Heterozygosity for homocysteinuria: a detectable and reversible risk factor for pulmonary thromboembolism.同型胱氨酸尿症杂合子:肺血栓栓塞可检测且可逆的危险因素。
Monaldi Arch Chest Dis. 1995 Apr;50(2):114-5.
2
[Homocysteine and venous thromboembolism].
Schweiz Med Wochenschr. 1997 Sep 6;127(36):1489-96.
3
Thromboembolism in a patient with transient eosinophilia.
Ann Hematol. 1996 Feb;72(2):93-5. doi: 10.1007/BF00641316.
4
[Evidence-based guidelines for prevention and therapy of venous thromboembolism].[静脉血栓栓塞症预防与治疗的循证指南]
Minerva Cardioangiol. 2000 Dec;48(12 Suppl 1):27-35.
5
A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.一项关于腔静脉滤器预防近端深静脉血栓形成患者肺栓塞的临床试验。腔静脉阻断预防肺栓塞风险研究组。
N Engl J Med. 1998 Feb 12;338(7):409-15. doi: 10.1056/NEJM199802123380701.
6
Prophylaxis of venous thrombosis and pulmonary embolism in patients with acute traumatic spinal cord lesions.
Paraplegia. 1977 Nov;15(3):209-14. doi: 10.1038/sc.1977.31.
7
[Pulmonary thromboembolism in the elderly].[老年人肺血栓栓塞症]
Ann Ital Med Int. 1987 Jan-Mar;2(1):12-21.
8
Prophylaxis of deep venous thrombosis and pulmonary embolism. Current recommendations.
Med Clin North Am. 1998 May;82(3):477-93. doi: 10.1016/s0025-7125(05)70006-7.
9
Management of deep vein thrombosis in spinal cord injury.脊髓损伤中深静脉血栓的管理。
Chest. 1992 Dec;102(6 Suppl):652S-657S.
10
Treatment of pulmonary embolism and deep vein thrombosis with thrombolytic therapy.用溶栓疗法治疗肺栓塞和深静脉血栓形成。
Clin Chest Med. 1984 Sep;5(3):487-94.